| 摘要 |
FIELD: chemistry. ^ SUBSTANCE: invention concerns novel polymorphous form of 3-phenylsulfonyl -8-piperasine-1-yl-quinoline characterised by: infrared spectre with peaks at 724, 758, 777, 804, 818, 838, 856, 905, 918, 948, 1023, 1055, 1081, 1092, 1118, 1136, 1153, 1178, 1244, 1302, 1318, 1365, 1378, 1403, 1444, 1471, 1490, 1569, 1584, 1603 and 2819 cm-1, combination scattering spectre with peaks at 159, 184, 214, 241, 285, 304, 318, 429, 545, 558, 614, 706, 724, 803, 856, 1000, 1023, 1080, 1093, 1136, 1152, 1233, 1243, 1317, 1343, 1364, 1378, 1403, 1446, 1569, 1584, 1602, 3050 and 3073 cm-1, X-ray powder difractogram (XRPD) with calculated interplanar distances at angle values of 10.29, 11.94, 17.47, 19.55, 19.84 and 20.33 and melting point of 188C. ^ EFFECT: pharmaceutical composition based on the claimed compound, and its application in central nervous system disorder treatment. ^ 27 cl, 3 dwg, 3 ex |
